If you would like to inquire about all open trials, please contact 919.684.3401.
3 trials identified.
PBTC-029B: A Phase 1 and Phase II (B) and Re-Treatment (C) Study of AZD6244 for Recurrent or Refractory Pediatric Low Grade Glioma Phase: Phase II Sponsor: Cooperative Group Initiated Principal Investigator: Daniel Landi Contact: Jennifer King, RN Phone: 919.668.5364 Reference Number: 00023836 View this trial at ClinicalTrials.gov
PBTC-042: Phase I Study of CDK 4-6 Inhibitor PD-0332991 (palbociclib; IBRANCE) in Children with Recurrent, Progressive or Refractory Central Nervous System Tumors Phase: Phase I Sponsor: Cooperative Group Initiated Principal Investigator: David Vanmater Contact: Jennifer King, RN Phone: 919.668.5364 Reference Number: 00054303 View this trial at ClinicalTrials.gov
ACCL10P1 Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study Phase: N/A Sponsor: Cooperative Group Initiated Principal Investigator: Susan Kreissman Contact: Pediatric Oncology Clinical Research Team Phone: 919.684.3401 Reference Number: 00081175 View this trial at ClinicalTrials.gov
Ways To Give
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.